Literature DB >> 19001449

In vitro activity of an aqueous allicin extract and a novel allicin topical gel formulation against Lancefield group B streptococci.

Ronald R Cutler1, Michel Odent, Hussein Hajj-Ahmad, Sunil Maharjan, Norman J Bennett, Peter D Josling, Vanessa Ball, Paulette Hatton, Martino Dall'Antonia.   

Abstract

BACKGROUND: Studies have shown the efficacy of intra-partum antibiotics in preventing early-onset group B streptococcal sepsis. This approach results in a high intra-partum antibiotic use. Worryingly, the same antibiotics used in prophylaxis are also first-line treatment for neonatal sepsis, and antibiotic exposure in the peri-natal period has been shown to be a risk factor for late-onset serious bacterial infections and allergic disease. Antibiotic exposure in the peri-natal period is becoming a major public health issue; alternative strategies are needed. Garlic has been traditionally used to treat vaginal infections. Allicin is the main antibacterial agent isolated from garlic.
OBJECTIVES: The aim of the study was to investigate the in vitro activity of a novel allicin extract in aqueous and gel formulation against 76 clinical isolates of Lancefield group B streptococci (GBS).
METHODS: MICs and MBCs of allicin were determined for 76 GBS isolates by agar dilution and microtitre plate methods. Killing kinetics were determined for a selected 16 of the 76 strains. Agar diffusion tests were compared for allicin liquid and gel (500 mg/L). RESULTS AND
CONCLUSIONS: MICs and MBCs of allicin liquid were 35 to 95 mg/L and 75 to 315 mg/L, respectively. Time/dose kill curves produced a 2-3 log reduction in cfu/mL within 3 h and no detectable growth at 8 and 24 h. A novel 500 mg/L allicin gel produced an average zone size of 23+/-6 mm compared with 21+/-6 mm for allicin in water. Aqueous allicin is bactericidal against GBS isolates and maintains activity in a novel gel formulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19001449     DOI: 10.1093/jac/dkn457

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

Review 1.  Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis.

Authors:  Joyce M Koenig; William J Keenan
Journal:  Pediatr Clin North Am       Date:  2009-06       Impact factor: 3.278

2.  Inhibition of Staphylococcus aureus Adhesion to the Surface of a Reticular Heavyweight Polypropylene Mesh Soaked in a Combination of Chlorhexidine and Allicin: An In vitro Study.

Authors:  Bárbara Pérez-Köhler; Francisca García-Moreno; Yves Bayon; Gemma Pascual; Juan Manuel Bellón
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

Review 3.  Transient receptor potential channels as targets for phytochemicals.

Authors:  Louis S Premkumar
Journal:  ACS Chem Neurosci       Date:  2014-06-24       Impact factor: 4.418

4.  Garlic: An Alternative Treatment for Group B Streptococcus.

Authors:  Kátia Andrea de Menezes Torres; Sônia Maria Rolim Rosa Lima; Luce Maria Brandão Torres; Maria Thereza Gamberini; Pedro Ismael da Silva Junior
Journal:  Microbiol Spectr       Date:  2021-11-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.